Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: VEGF-B | Statement: [aflibercept, targets, VEGF-B]

Target entity: VEGF-B
Context triple: [aflibercept, targets, VEGF-B]

• A. platelet-derived growth factor
  Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
• B. IN-2
  IN-2 is the standard postal-style abbreviation used to refer to Indiana's 2nd congressional district in the U.S. House of Representatives.
• C. aflibercept
  Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
• D. EGF
  EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
• E. B-VG
  B-VG is the commonly used abbreviation for Austria’s Federal Constitutional Law, which forms the core of the country’s constitutional framework.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: VEGF-B
Triple: [aflibercept, targets, VEGF-B]

VEGF-B is a member of the vascular endothelial growth factor family involved in blood vessel biology and tissue survival, particularly in the heart and nervous system.

Target entity: VEGF-B
Target entity description: VEGF-B is a member of the vascular endothelial growth factor family involved in blood vessel biology and tissue survival, particularly in the heart and nervous system.

• A. platelet-derived growth factor
  Platelet-derived growth factor is a key signaling protein that regulates cell growth, proliferation, and angiogenesis, and plays important roles in wound healing and various pathological conditions such as cancer and fibrosis.
• B. IN-2
  IN-2 is the standard postal-style abbreviation used to refer to Indiana's 2nd congressional district in the U.S. House of Representatives.
• C. aflibercept
  Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
• D. EGF
  EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
• E. B-VG
  B-VG is the commonly used abbreviation for Austria’s Federal Constitutional Law, which forms the core of the country’s constitutional framework.
• F. None of above. chosen